Kozak & Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14
| Closed | -$2.65K | – | 442 |
|
|
2024
Q3 | $2.65K | Hold |
14
| – | – | ﹤0.01% | 318 |
|
|
2024
Q2 | $3.15K | Hold |
14
| – | – | ﹤0.01% | 294 |
|
|
2024
Q1 | $3.22K | Hold |
14
| – | – | ﹤0.01% | 301 |
|
|
2023
Q4 | $3.45K | Sell |
14
-30
| -68% | -$7.39K | ﹤0.01% | 291 |
|
|
2023
Q3 | $11.6K | Hold |
44
| – | – | ﹤0.01% | 227 |
|
|
2023
Q2 | $12.6K | Hold |
44
| – | – | 0.01% | 213 |
|
|
2023
Q1 | $12.2K | Hold |
44
| – | – | 0.01% | 216 |
|
|
2022
Q4 | $12K | Hold |
44
| – | – | 0.01% | 216 |
|
|
2022
Q3 | $11K | Hold |
44
| – | – | 0.01% | 214 |
|
|
2022
Q2 | $9K | Sell |
44
-740
| -94% | -$151K | 0.01% | 234 |
|
|
2022
Q1 | $156K | Hold |
784
| – | – | 0.1% | 85 |
|
|
2021
Q4 | $156K | Hold |
784
| – | – | 0.1% | 85 |
|
|
2021
Q3 | $213K | Buy |
+784
| New | +$213K | 0.13% | 77 |
|
|
2020
Q4 | $208K | Buy |
+784
| New | +$208K | 0.16% | 65 |
|